https://cladribineinhibitor.co....m/effect-from-the-co
Outcomes TERT promoter alterations in two hotspots (C228T and C250T) and C216T were found in 16 (2.2%) and 4 (0.6%) of all PTCs, respectively. The hotspot mutations were dramatically associated with older age at diagnosis, bigger tumefaction dimensions, extrathyroidal expansion, greater pathologic T category, lateral lymph node metastasis, and higher American Thyroid Association recurrence risk. The patients with C216T variant had been more youthful along with a reduced American Thyroid
Like
Comment
Share
